Readnour Robin Shane - Insider Non-Derivative Transactions at AN2 Therapeutics, Inc. (ANTX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jan 12, 2024, Readnour Robin Shane's relationship to AN2 Therapeutics, Inc. (ANTX) is Director, and currently has 485,073 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ANTX insiders.
Data Source: SEC.
Readnour Robin Shane - Insider Non-Derivative Transactions of ANTX Common Stock
Readnour Robin Shane - Insider Non-Derivative Transactions at ANTX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jan 13, 2024 | Sell -- (Common Stock) | 706 | 21.92 | 414788 |
| Jan 13, 2024 | Sell -- (Common Stock) | 719 | 21.91 | 485073 |
| Jan 11, 2024 | Sell -- (Common Stock) | 1869 | 21.93 | 415494 |
| Jan 11, 2024 | Sell -- (Common Stock) | 1800 | 21.92 | 485792 |